Cargando…
Immune Evasion Mechanism and AXL
Extensive interest in cancer immunotherapy is reported according to the clinical importance of CTLA-4 and (PD-1/PD-L1) [programmed death (PD) and programmed death-ligand (PD-L1)] in immune checkpoint therapies. AXL is a receptor tyrosine kinase expressed in different types of cancer and in relation...
Autores principales: | Son, Hye-Youn, Jeong, Hwan-Kyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581356/ https://www.ncbi.nlm.nih.gov/pubmed/34778071 http://dx.doi.org/10.3389/fonc.2021.756225 |
Ejemplares similares
-
Mechanisms of Immune Evasion and Immune Modulation by Lymphoma Cells
por: Menter, Thomas, et al.
Publicado: (2018) -
Enhancing the Efficacy of Tumor Vaccines Based on Immune Evasion Mechanisms
por: Chen, Jianyu, et al.
Publicado: (2021) -
The mechanisms on evasion of anti-tumor immune responses in gastric cancer
por: Wang, Junyang, et al.
Publicado: (2022) -
Deciphering immune microenvironment and cell evasion mechanisms in human gliomas
por: Rafii, Soumaya, et al.
Publicado: (2023) -
The Sweet Side of Immune Evasion: Role of Glycans in the Mechanisms of Cancer Progression
por: Nardy, Ana Flávia Fernandes Ribas, et al.
Publicado: (2016)